Objective: To observe the pharmacokinetical character of borneol in the plasma of patients with coronary heart disease taking Suxiaojiuxin Pills. Methods: Six patients with coronary heart disease taking Suxiaojiuxin Pills, the concentration of borneol in the plasma was determined at the different time. Results: The concentration-time data analysis of borneol in the patients with coronary heart disease showed to fit a single compartment open model, and borneol reached the highest peak of the concentration of borneol in the plasma after 16min. Conclusion: The definitude of the pharmacokinetical character of borneol in the patients with coronary heart disease taking Suxiaojiuxin Pills provides guantified data for clinic.